Raverot G, Arnous W, Calender A, Trouillas J, Sassolas G, Bournaud C, Pugeat M, Borson-Chazot F
Fédération d'Endocrinologie du Pôle Est, Hospices Civils de Lyon, Lyon, France.
J Endocrinol Invest. 2007 Oct;30(9):787-90. doi: 10.1007/BF03350819.
Familial pituitary adenoma is a rare syndrome which may present either as isolated lesions, or in association with other endocrine tumors, for example in the frame of multiple endocrine neoplasia (MEN-1) or Carney complex (CNC). The most frequently described forms of familial isolated pituitary adenoma (FIPA) are familial somatotropinomas or prolactinomas. Recently, some cases of familial isolated somatotropinoma have been associated with germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. The present report shows heterogeneous FIPA with 3 subtypes of tumor in 3 individuals of the same family: somatotropinoma in the proband, giant prolactinoma in a brother, and gonadotroph cell macroadenoma in the father. A prospective survey also suggested the occurrence of a silent microadenoma in the proband's sister. Clinical screening was performed in the 3 affected members, the 4th suspected case, and 9 additional, asymptomatic relatives. They had no clinical evidence of associated endocrine lesion suggesting MEN-1 or CNC. Genetic screening for germline mutation of the MEN-1, the gene encoding the protein kinase A (PKA) type 1 alpha regulatory subunit (R1 alpha) (PRKAR1alpha) and AIP gene was negative in 2 affected members. In conclusion, these data suggest that familial pituitary adenomas can occur with a heterogeneous functional pattern that is distinguished from MEN-1 or CNC. The absence of mutation of the recently described AIP gene suggests the implication of other predisposing gene(s). Collaborative, multicentric studies are needed to further define the location of gene(s) involved in heterogeneous FIPA.
家族性垂体腺瘤是一种罕见的综合征,可表现为孤立性病变,或与其他内分泌肿瘤相关,例如在多发性内分泌腺瘤病1型(MEN-1)或卡尼综合征(CNC)的情况下。最常描述的家族性孤立性垂体腺瘤(FIPA)形式是家族性生长激素瘤或催乳素瘤。最近,一些家族性孤立性生长激素瘤病例与芳烃受体相互作用蛋白(AIP)基因的种系突变有关。本报告显示了一个家族中3名个体的异质性FIPA,有3种肿瘤亚型:先证者为生长激素瘤,其兄弟为巨大催乳素瘤,父亲为促性腺激素细胞大腺瘤。一项前瞻性调查还提示先证者的妹妹存在无症状微腺瘤。对3名患病成员、第4名疑似病例以及另外9名无症状亲属进行了临床筛查。他们没有提示MEN-1或CNC的相关内分泌病变的临床证据。对MEN-1、编码蛋白激酶A(PKA)1型α调节亚基(R1α)(PRKAR1α)的基因和AIP基因进行种系突变的基因筛查,结果在2名患病成员中为阴性。总之,这些数据表明家族性垂体腺瘤可呈现异质性功能模式,与MEN-1或CNC不同。最近描述的AIP基因未发生突变提示其他易感基因的参与。需要开展协作性多中心研究,以进一步明确参与异质性FIPA的基因定位。